Literature DB >> 22924847

Clinicopathological study of Japanese patients with genetic iron overload syndromes.

Ai Hattori1, Hiroaki Miyajima, Naohisa Tomosugi, Yasuaki Tatsumi, Hisao Hayashi, Shinya Wakusawa.   

Abstract

In addition to hemochromatosis, aceruloplasminemia and ferroportin disease may be complicated by iron-induced multiple organ damage. Therefore, clinicopathological features should be evaluated in a wider range of genetic iron disorders. This study included 16 Japanese patients with genetic iron overload syndromes. The responsible genes were CP in four, HAMP in one, HJV in three, TFR2 in five, and SLC40A1 in three patients. No phenotype dissociation was observed in patients with the CP, TFR2, or HAMP genotypes. Two of the three patients with the HJV genotype displayed classic hemochromatosis instead of the juvenile type. Patients with the SLC40A1 genotype were affected by mild iron overload (ferroportin A) or severe iron overload (ferroportin B). Transferrin saturation was unusually low in aceruloplasminemia patients. All patients, except those with ferroportin disease, displayed low serum hepcidin-25 levels. Liver pathology showed phenotype-specific changes; isolated parenchymal iron loading in aceruloplasminemia, periportal fibrosis associated with heavy iron overload in both parenchymal and Kupffer cells of ferroportin B, and parenchyma-dominant iron-loading cirrhosis in hemochromatosis. In contrast, diabetes occurred in all phenotypes of aceruloplasminemia, hemochromatosis, and ferroportin disease B. In conclusion, clinicopathological features were partially characterized in Japanese patients with genetic iron overload syndromes.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924847     DOI: 10.1111/j.1440-1827.2012.02848.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  13 in total

1.  Inclusion bodies of aggregated hemosiderins in liver macrophages.

Authors:  Hisao Hayashi; Yasuaki Tatsumi; Shinya Wakusawa; Ryota Shigemasa; Ryoji Koide; Ken-Ichi Tsuchida; Natsuko Morotomi; Tetsuji Yamashita; Kotaro Kumagai; Yukiya Ono; Kazuhiko Hayashi; Masatoshi Ishigami; Hidemi Goto; Ayako Kato; Koichi Kato
Journal:  Med Mol Morphol       Date:  2017-06-19       Impact factor: 2.309

Review 2.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

3.  A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.

Authors:  Tetsuji Yamashita; Natsuko Morotomi; Tetsuro Sohda; Hisao Hayashi; Naohiko Yoshida; Keiko Ochi; Izumi Ohkura; Mika Karita; Hiroko Fujiwara; Haruhiko Yamashita; Ai Hattori; Yasuaki Tatsumi
Journal:  Clin J Gastroenterol       Date:  2014-04-19

Review 4.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

5.  Iron overload patients with unknown etiology from national survey in Japan.

Authors:  Katsuya Ikuta; Mayumi Hatayama; Lynda Addo; Yasumichi Toki; Katsunori Sasaki; Yasuaki Tatsumi; Ai Hattori; Ayako Kato; Koichi Kato; Hisao Hayashi; Takahiro Suzuki; Masayoshi Kobune; Miyuki Tsutsui; Akihiko Gotoh; Yasuo Aota; Motoo Matsuura; Yuzuru Hamada; Takahiro Tokuda; Norio Komatsu; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

6.  PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.

Authors:  Shinsaku Imashuku; Hideki Muramatsu; Takashi Sugihara; Yusuke Okuno; Xinan Wang; Kenichi Yoshida; Ayako Kato; Koichi Kato; Yasuaki Tatsumi; Ai Hattori; Shinya Kita; Keishi Oe; Atsushi Sueyoshi; Takeshi Usui; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hitoshi Kanno
Journal:  Int J Hematol       Date:  2016-03-14       Impact factor: 2.490

7.  Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload.

Authors:  Haruhiko Ohashi; Kayo Arita; Yasuhiro Suzuki; Akihiro Tomita; Tomoki Naoe; Ai Hattori; Yasuaki Tatsumi; Koichi Kato; Hirokazu Nagai
Journal:  Int J Hematol       Date:  2012-12-04       Impact factor: 2.490

Review 8.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

9.  Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.

Authors:  Yukiya Ono; Masatoshi Ishigami; Kazuhiko Hayashi; Shinya Wakusawa; Hisao Hayashi; Kotaro Kumagai; Natsuko Morotomi; Tetsuji Yamashita; Miwa Kawanaka; Minemori Watanabe; Hiroaki Ozawa; Mayumi Tai; Hiroaki Miyajima; Kentarou Yoshioka; Yoshiki Hirooka; Hidemi Goto
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

10.  A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.

Authors:  Hisao Hayashi; Motoyoshi Yano; Naohito Urawa; Akane Mizutani; Shima Hamaoka; Jun Araki; Yuji Kojima; Yutaka Naito; Ayako Kato; Yasuaki Tatsumi; Koichi Kato
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.